AI Signal & Stock Analysis · Very Strong ↑
As of Aug 14 2026, 1:04 PM, AkshayaAI's signal for GMED is Very Strong ↑; the stock is at $86.01 (+0.08% today); neutral (RSI 63); technical trend is Raise; news sentiment is positive.
Data as of Aug 14 2026, 1:04 PM. Informational analytics only — not investment advice.
| AI signal (Strength) | Very Strong ↑ |
|---|---|
| Price | $86.01 |
| Change today | +0.08% |
| RSI (14) | 63.14 |
| Relative volume | 0.27 |
| Composite (RMTPGV) score | 🔒 members |
| Market cap | $11.5B |
| Forward P/E | 16.07 |
| 52-week high | -15.1% away |
| 52-week low | +59.0% above |
| Technical trend | RAISE-2024-01-26 |
| News sentiment | Positive |
| Sector | Healthcare-Devices |
| Next earnings | 8/6/2026 4:30:00 PM |
As of Aug 14 2026, 1:04 PM, AkshayaAI assigns GMED (Globus Medical Inc) a Very Strong signal. The composite (RMTPGV) score and full factor breakdown are available to signed-in members.
GMED's RSI is neutral (RSI 63). A reading above 70 is typically considered overbought and below 30 oversold.
GMED is trading about 15% below its 52-week high and 59% above its 52-week low as of Aug 14 2026, 1:04 PM.
GMED's next earnings date is 8/6/2026 4:30:00 PM.
GMED is classified under Healthcare-Devices in AkshayaAI's taxonomy.
AkshayaAI provides AI-generated, informational stock analytics for US and India markets. This is not personalized investment advice. Figures are as of Aug 14 2026, 1:04 PM and may not reflect real-time prices. Always do your own research.
Instant, data-backed answers — free to try.